Effects of designed PLLA and 50:50 PLGA scaffold architectures on bone formation in vivo

Journal of Tissue Engineering and Regenerative Medicine

Volumn 7, Issue 2, 2013, Pages 99-111

  Saito, Eiji ^a   Liao, Elly E ^a   Hu, Wei Wen ^d   Krebsbach, Paul H ^a,b   Hollister, Scott J ^a,c  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN SCHOOL OF DENTISTRY   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d NATIONAL CENTRAL UNIVERSITY   (Taiwan)

Author keywords

Bone regeneration; Degradation; Designed architecture; Poly (L lactic acid); Poly (lactic co glycolic acid); Scaffold; Solid freeform fabrication

Indexed keywords

BIODEGRADABLE POLYMERS; BIOMECHANICS; BONE; CELL CULTURE; COMPUTERIZED TOMOGRAPHY; FABRICATION; LACTIC ACID; PHASE SEPARATION; POLYMERIC IMPLANTS; SCAFFOLDS (BIOLOGY);

BONE FORMATION; BONE REGENERATION; BONE TISSUE; DESIGNED ARCHITECTURE; POLY (L-LACTIC ACID); POLY (LACTIC-CO-GLYCOLIC ACID); POLY LACTIC-CO-GLYCOLIC ACID; POLY(LACTIC-CO-GLYCOLIC ACID); POLY-L-LACTIC ACIDS; POROUS SCAFFOLD;

TISSUE REGENERATION;

OSTEOGENIC PROTEIN 1; POLYGLACTIN; POLYLACTIDE; TISSUE SCAFFOLD;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOMECHANICS; BONE GROWTH; BONE MASS; BONE TISSUE; COMPUTER ASSISTED TOMOGRAPHY; FIBROBLAST; GINGIVA; HISTOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; OSSIFICATION; PRIORITY JOURNAL; TISSUE REGENERATION; YOUNG MODULUS;

EID: 84873307992     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.497     Document Type: Article

References (66)

1. Athanasiou KA, Agrawal CM, Barber FA, et al. 1998; Orthopaedic applications for PLA-PGA biodegradable polymers. Arthroscopy 14: 726-737.
2. Bessa PC, Casal M, Reis RL. 2008a; Bone morphogenetic proteins in tissue engineering: the road from laboratory to clinic, part II (BMP delivery). J Tissue Eng Regen Med 2: 81-96.
3. Bessa PC, Casal M, Reis RL. 2008b; Bone morphogenetic proteins in tissue engineering: the road from the laboratory to the clinic, part I (basic concepts). J Tissue Eng Regen Med 2: 1-13.
4. Cao Y, Mitchell G, Messina A, et al. 2006; The influence of architecture on degradation and tissue ingrowth into three-dimensional poly(lactic-co-glycolic acid) scaffolds in vitro and in vivo. Biomaterials 27: 2854-2864.
5. Chang SC, Chuang HL, Chen YR, et al. 2003; Ex vivo gene therapy in autologous bone marrow stromal stem cells for tissue-engineered maxillofacial bone regeneration. Gene Ther 10: 2013-2019.
6. Claase MB, de Bruijn JD, Grijpma DW, et al. 2007; Ectopic bone formation in cell-seeded poly(ethylene oxide)/poly(butylene terephthalate) copolymer scaffolds of varying porosity. J Mater Sci Mater Med 18: 1299-1307.
7. Druecke D, Langer S, Lamme E, et al. 2004; Neovascularization of poly (ether ester) block-copolymer scaffolds in vivo: long-term investigations using intravital fluorescent microscopy. J Biomed Mater Res A 68: 10-18.
8. Duty AO, Oest ME, Guldberg RE. 2007; Cyclic mechanical compression increases mineralization of cell-seeded polymer scaffolds in vivo. J Biomech Eng 129: 531-539.
9. Franceschi RT, Wang D, Krebsbach PH, et al. 2000; Gene therapy for bone formation: in vitro and in vivo osteogenic activity of an adenovirus expressing BMP7. J Cell Biochem 78: 476-486.
10. Goldstein AS, Zhu G, Morris GE, et al. 1999; Effect of osteoblastic culture conditions on the structure of poly(DL-lactic-co-glycolic acid) foam scaffolds. Tissue Eng 5: 421-434.
11. Gomes ME, Holtorf HL, Reis RL, et al. 2006; Influence of the porosity of starch-based fiber mesh scaffolds on the proliferation and osteogenic differentiation of bone marrow stromal cells cultured in a flow perfusion bioreactor. Tissue Eng 12: 801-809.
12. Hirata K, Tsukazaki T, Kadowaki A, et al. 2003; Transplantation of skin fibroblasts expressing BMP-2 promotes bone repair more effectively than those expressing Runx2. Bone 32: 502-512.
13. Hollister SJ. 2005; Porous scaffold design for tissue engineering. Nat Mate 4: 518-524.
14. Hollister SJ, Levy RA, Chu TM, et al. 2000; An image-based approach for designing and manufacturing craniofacial scaffolds. Int J Oral Maxillofac Surg 29: 67-71.
15. Hollister SJ, Maddox RD, Taboas JM. 2002; Optimal design and fabrication of scaffolds to mimic tissue properties and satisfy biological constraints. Biomaterials 23: 4095-4103.
16. Hsu SH, Yen HJ, Tseng CS, et al. 2007; Evaluation of the growth of chondrocytes and osteoblasts seeded into precision scaffolds fabricated by fused deposition manufacturing. J Biomed Mater Res B Appl Biomater 80: 519-527.
17. Hui PW, Leung PC, Sher A. 1996; Fluid conductance of cancellous bone graft as a predictor for graft-host interface healing. J Biomech 29: 123-132.
18. Hutmacher DW. 2001; Scaffold design and fabrication technologies for engineering tissues--state of the art and future perspectives. J Biomater Sci Polym Ed 12: 107-124.
19. Hutmacher DW, Schantz T, Zein I, et al. 2001; Mechanical properties and cell cultural response of polycaprolactone scaffolds designed and fabricated via fused deposition modelling. J Biomed Mater Res 55: 203-216.
20. Hutmacher DW, Sittinger M, Risbud MV. 2004; Scaffold-based tissue engineering: rationale for computer-aided design and solid free-form fabrication systems. Trends Biotechnol 22: 354-362.
21. Ishaug-Riley SL, Crane GM, Gurlek A, et al. 1997; Ectopic bone formation by marrow stromal osteoblast transplantation using poly(DL-lactic-co-glycolic acid) foams implanted into the rat mesentery. J Biomed Mater Res 36: 1-8.
22. Ishaug-Riley SL, Crane-Kruger GM, Yaszemski MJ, et al. 1998; Three-dimensional culture of rat calvarial osteoblasts in porous biodegradable polymers. Biomaterials 19: 1405-1412.
23. Ishaug-Riley SL, Okun LE, Prado G, et al. 1999; Human articular chondrocyte adhesion and proliferation on synthetic biodegradable polymer films. Biomaterials 20: 2245-2256.
24. Jones AC, Arns CH, Hutmacher DW, et al. 2009; The correlation of pore morphology, interconnectivity and physical properties of 3D ceramic scaffolds with bone ingrowth. Biomaterials 30: 1440-1451.
25. Kang Y, Yao Y, Yin G, et al. 2009; A study on the in vitro degradation properties of poly(L-lactic acid)/beta-tricalcuim phosphate (PLLA/beta-TCP) scaffold under dynamic loading. Med Eng Phys 31: 589-594.
26. Karageorgiou V, Kaplan D. 2005; Porosity of 3D biomaterial scaffolds and osteogenesis. Biomaterials 26: 5474-5491.
27. Kaushiva A, Turzhitsky VM, Darmoc M, et al. 2007; A biodegradable vascularizing membrane: a feasibility study. Acta Biomater 3: 631-642.
28. Keaveny TM, Morgan EF, Niebur GL, Yeh OC. 2001; Biomechanics of trabecular bone. Annu Rev Biomed Eng 3: 307-333.
29. Khan Y, Yaszemski MJ, Mikos AG, et al. 2008; Tissue engineering of bone: material and matrix considerations. J Bone Joint Surg Am 90 Suppl 1: 36-42.
30. Kohn DH, Sarmadi M, Helman JI, et al. 2002; Effects of pH on human bone marrow stromal cells in vitro: implications for tissue engineering of bone. J Biomed Mater Re 60: 292-299.
31. Kontakis GM, Pagkalos JE, Tosounidis TI, et al. 2007; Bioabsorbable materials in orthopaedics. Acta Orthop Belg 73: 159-169.
32. Krebsbach PH, Gu K, Franceschi RT, et al. 2000; Gene therapy-directed osteogenesis: BMP-7-transduced human fibroblasts form bone in vivo. Hum Gene Ther 11: 1201-1210.
33. Kruyt MC, Dhert WJ, Oner FC, et al. 2007; Analysis of ectopic and orthotopic bone formation in cell-based tissue-engineered constructs in goats. Biomaterials 28: 1798-1805.
34. Kuboki Y, Jin Q, Takita H. 2001; Geometry of carriers controlling phenotypic expression in BMP-induced osteogenesis and chondrogenesis. J Bone Joint Surg Am 83-A Suppl 1: S105-S115.
35. Li JP, Habibovic P, van den Doel M, et al. 2007; Bone ingrowth in porous titanium implants produced by 3D fiber deposition. Biomaterials 28: 2810-2820.
36. Li WJ, Cooper JA Jr, Mauck RL, et al. 2006; Fabrication and characterization of six electrospun poly(alpha-hydroxy ester)-based fibrous scaffolds for tissue engineering applications. Acta Biomater 2: 377-385.
37. Lin CY, Kikuchi N, Hollister SJ. 2004; A novel method for biomaterial scaffold internal architecture design to match bone elastic properties with desired porosity. J Biomech 37: 623-636.
38. Lin CY, Schek RM, Mistry AS, et al. 2005; Functional bone engineering using ex vivo gene therapy and topology-optimized, biodegradable polymer composite scaffolds. Tissue Eng 11: 1589-1598.
39. Lu L, Peter SJ, Lyman MD, et al. 2000; In vitro and in vivo degradation of porous poly (DL-lactic-co-glycolic acid) foams. Biomaterials 21: 1837-1845.
40. Martins A, Chung S, Pedro AJ, et al. 2009; Hierarchical starch-based fibrous scaffold for bone tissue engineering applications. Tissue Eng Regen Med 3: 37-42.
41. Melchels FP, Barradas AM, van Blitterswijk CA, et al. 2010; Effects of the architecture of tissue engineering scaffolds on cell seeding and culturing. Acta Biomater 6: 4208-4217.
42. Middleton JC, Tipton AJ. 2000; Synthetic biodegradable polymers as orthopedic devices. Biomaterials 21: 2335-2346.
43. Narayan D, Venkatraman SS. 2008; Effect of pore size and interpore distance on endothelial cell growth on polymers. J Biomed Mater Res A 87: 710-718.
44. Nussenbaum B, Krebsbach PH. 2006; The role of gene therapy for craniofacial and dental tissue engineering. Adv Drug Deliv Rev 58: 577-591.
45. Oh SH, Kang SG, Kim ES, et al. 2003; Fabrication and characterization of hydrophilic poly(lactic-co-glycolic acid)/poly(vinyl alcohol) blend cell scaffolds by melt-molding particulate-leaching method. Biomaterials 24: 4011-4021.
46. Oh SH, Park IK, Kim JM, et al. 2007; In vitro and in vivo characteristics of PCL scaffolds with pore size gradient fabricated by a centrifugation method. Biomaterials 28: 1664-1671.
47. Pamula E, Bacakova L, Filova E, et al. 2008a; The influence of pore size on colonization of poly(L-lactide-glycolide) scaffolds with human osteoblast-like MG 63 cells in vitro. J Mater Sci Mater Med 19: 425-435.
48. Pamula E, Filova E, Bacakova L, et al. 2008b; Resorbable polymeric scaffolds for bone tissue engineering: The influence of their microstructure on the growth of human osteoblast-like MG 63 cells. J Biomed Mater Res A 89(2): 432-443.
49. Rezwan K, Chen QZ, Blaker JJ, et al. 2006; Biodegradable and bioactive porous polymer/inorganic composite scaffolds for bone tissue engineering. Biomaterials 27: 3413-3431.
50. Robinson BP, Hollinger JO, Szachowicz EH, et al. 1995; Calvarial bone repair with porous D, L-polylactide. Otolaryngol Head Neck Surg 112: 707-713.
51. Roosa SM, Kemppainen JM, Moffitt EN, et al. 2010; The pore size of polycaprolactone scaffolds has limited influence on bone regeneration in an in vivo model. J Biomed Mater Res A 92: 359-368.
52. Rose FR, Cyster LA, Grant DM, et al. 2004; In vitro assessment of cell penetration into porous hydroxyapatite scaffolds with a central aligned channel. Biomaterials 25: 5507-5514.
53. Rutherford RB, Moalli M, Franceschi RT, et al. 2002; Bone morphogenetic protein-transduced human fibroblasts convert to osteoblasts and form bone in vivo. Tissue Eng 8: 441-452.
54. Rutherford RB, TrailSmith MD, Ryan ME, et al. 1992; Synergistic effects of dexamethasone on platelet-derived growth factor mitogenesis in vitro. Arch Oral Biol 37: 139-145.
55. Saito E, Kang H, Taboas JM, et al. 2010; Experimental and computational characterization of designed and fabricated 50:50 PLGA porous scaffolds for human trabecular bone applications. J Mater Sci Mater Med 21: 2371-2383.
56. Schek RM, Wilke EN, Hollister SJ, et al. 2006; Combined use of designed scaffolds and adenoviral gene therapy for skeletal tissue engineering. Biomaterials 27: 1160-1166.
57. Shin JH, Kim KH, Kim SH, et al. 2010; Ex vivo bone morphogenetic protein-2 gene delivery using gingival fibroblasts promotes bone regeneration in rats. J Clin Periodontol 37: 305-311.
58. Silva MM, Cyster LA, Barry JJ, et al. 2006; The effect of anisotropic architecture on cell and tissue infiltration into tissue engineering scaffolds. Biomaterials 27: 5909-5917.
59. Sinha RK, Morris F, Shah SA, et al. 1994; Surface composition of orthopaedic implant metals regulates cell attachment, spreading, and cytoskeletal organization of primary human osteoblasts in vitro. Clin Orthop Relat Res (305): 258-272.
60. Sosnowski S, Wozniak P, Lewandowska-Szumiel M. 2006; Polyester scaffolds with bimodal pore size distribution for tissue engineering. Macromol Biosci 6: 425-434.
61. Sun W, Starly B, Darling A, et al. 2004; Computer-aided tissue engineering: application to biomimetic modelling and design of tissue scaffolds Biotechnol Appl Biochem 39: 49-58.
62. Taboas JM, Maddox RD, Krebsbach PH, et al. 2003; Indirect solid free form fabrication of local and global porous, biomimetic and composite 3D polymer-ceramic scaffolds. Biomaterials 24: 181-194.
63. Tsuruga E, Takita H, Itoh H, et al. 1997; Pore size of porous hydroxyapatite as the cell-substratum controls BMP-induced osteogenesis. J Biochem 121: 317-324.
64. Wei G, Jin Q, Giannobile WV, et al. 2007; The enhancement of osteogenesis by nano-fibrous scaffolds incorporating rhBMP-7 nanospheres. Biomaterials 28: 2087-2096.
65. Williams JM, Adewunmi A, Schek RM, et al. 2005; Bone tissue engineering using polycaprolactone scaffolds fabricated via selective laser sintering. Biomaterials 26: 4817-4827.
66. Wu YC, Shaw SY, Lin HR, et al. 2006; Bone tissue engineering evaluation based on rat calvaria stromal cells cultured on modified PLGA scaffolds. Biomaterials 27: 896-904.